U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07951333) titled 'Targeted Quality Improvement Trial to Improve Post-Discharge VTE' on Nov. 10.

Brief Summary: Venous thromboembolism (VTE) is the most common preventable cause of death after major abdominal and pelvic cancer surgery, and over one-third of events occur after discharge. National guidelines recommend extended post-discharge chemoprophylaxis, but hospital adherence varies widely. This observational study has two parts. Aim 1 uses interviews, focus groups, and surveys with patients, clinicians, and health system stakeholders to identify barriers and facilitators to implementing a post-discharge VTE chemoprophylaxis quality improvement pr...